Skip to headerSkip to main contentSkip to footer
Get our Free E-newslettersGet our Free E-newsletters
Kiplinger logoLink to homepage
Get our Free E-newslettersGet our Free E-newsletters
Subscribe to Kiplinger
Subscribe to Kiplinger
Save up to 76%
Subscribe
Subscribe to Kiplinger
  • Store
  • Home
  • Investing
  • Retirement
  • Taxes
  • Personal Finance
  • Your Business
  • Wealth Creation
    • Podcasts
    • Economic Outlooks
    • Tools
    • Kiplinger's Personal Finance Magazine
    • The Kiplinger Letter
    • The Kiplinger Tax Letter
    • Kiplinger's Investing for Income
    • Kiplinger's Retirement Report
    • Store
    • Manage My E-Newsletters
    • My Subscriptions
Skip advert
  • Home
  • investing
investing

Value Added: 7 Top Stocks for 2019

Making money in the stock market this year is going to take all the skill and luck you can muster.

by: Steven Goldberg
January 9, 2019
sale 50% off mock up advertise display frame setting over the clothes line in the shopping department store for shopping, business fashion and advertisement concept

Getty Images

Skip advert

Making money in the stock market this year is going to take all the skill and luck you can muster. The global economy is slowing, a trade war with China still lingers despite negotiations, and the Federal Reserve remains likely to raise short-term interest rates, albeit slowly.

But you still can find promising investments. To identify some of the top stocks right now, I interviewed Jerome Dodson, manager of Parnassus Endeavor Fund (PARWX) and founder of the Parnassus funds. Based in San Francisco, Parnassus is the largest U.S. fund firm focused on buying good stocks that are also, in the firm’s view, good corporate citizens in terms of the environment, social and corporate governance issues.

More to the point, Dodson’s fund has a first-class record. Endeavor returned an annualized 16.3% over the past 10 years – an average of 3.1 percentage points per year better than the Standard & Poor’s 500-stock index. Dodson, 75, is a contrarian investor who loves to pounce on stocks that have been pummeled.

Given the selloff, this is precisely Dodson’s kind of market. Read on for his seven top stocks for 2019.

  • 19 Best Retirement Stocks to Buy in 2019

Data is as of Jan. 8, 2019. Dividend yields are calculated by annualizing the most recent quarterly payout and dividing by the share price. Steve Goldberg writes a regular column, “Value Added.”

Skip advert
Skip advert
Skip advert

1 of 7

Apple

Koszalin, Poland – November 29, 2017: Space gray iPhone X and black iPhone 7. The iPhone X and iPhone 7 is smart phone with multi touch screen produced by Apple Computer, Inc.

Getty Images

Skip advert
  • 52-week low/high: $142.00/$233.47
  • Market value: $715.4 billion
  • Trailing P/E ratio: 13
  • Dividend yield: 1.9%
  • Apple (AAPL, $150.75) is a classic Dodson pick. Apple, of course, did a round trip, cresting around $233 before collapsing. It went from being everyone’s favorite stock to everyone’s most hated stock – with almost all the decline taking place in just the last three months of 2018. Then in early January, a fresh announcement of flagging sales of its signature iPhones, mainly in China, caused further damage to its stock price.

For Apple to turn around, Dodson says, it needs one big thing to happen: The U.S. and China must settle their trade differences without the U.S. putting big tariffs on imports of iPhones, which are assembled in China from parts manufactured in other Asian countries. Tariffs would force Apple to raise prices, trim profit margins, undertake a major revamping of its supply chain or, perhaps, all of the above.

“I’m assuming the trade spat will be settled,” Dodson says. “If Trump raises tariffs, that’d be really scary.”

Assuming common sense prevails, Dodson believes growth in Apple’s Services division – which includes iCloud, Apple Music, Apple Watch and iPay – will help make up for the longer periods users are holding onto their older iPhones, rather than buying newer, shinier models. But make no mistake: What Dodson really likes is Apple’s lower price. Shares trade at a level not seen since mid-2017. It’s not often a stock like Apple sells at a price-earnings ratio as low as 13.

Apple’s genius is that it sells products that really aren’t too dissimilar from everyone else’s. But once you own an iPhone, buying an Apple computer that so easily integrates with that phone is a no-brainer. Before you know it, you also own an iPad, an Apple Watch … and on it goes even though Apple’s prices are higher than most competitors. (By the way, I don’t own the stock, although several clients do. But I do own virtually all the Apple toys.)

 

  • The 9 Best Dividend Growth Stocks in the Dow Jones
Skip advert
Skip advert
Skip advert

2 of 7

Nvidia

Sofia, Bulgaria - 27 July 2018: NVIDIA GeForce chip is seen on a printed circuit board PCB. Computational equipment.

Getty Images

Skip advert
  • 52-week low/high: $124.46/$292.76
  • Market value: $85.3 billion
  • P/E ratio: 22
  • Dividend yield: 0.5%

Did I mention that Dodson likes to pick up the pieces after a stock crashes? Consider Nvidia (NVDA, $139.83), a leading designer of cutting-edge graphics processing units, which are used in a variety of high-end computer applications, especially for complex gaming software.

Nvidia became a cult stock because its chips were also widely used in computer mining of cryptocurrencies, such as Bitcoin. When the cryptocurrencies cratered, demand for some of Nvidia’s chips fell too, and failed to recover quickly. CEO Jensen Huang told a conference call in November that the company was suffering from a “crypto hangover.”

Nvidia’s future, thankfully, isn’t in cryptocurrency mining. Demand for its chips comes not just from gaming applications, but also from data centers and automotive infotainment centers. Nvidia’s chips also are increasingly being used in artificial intelligence and self-driving applications.

Dodson likes Nvidia’s P/E of 22. On an absolute basis, that’s fairly high, but Dodson likes to compare a forward P/E to a stock’s five-year history. Nvidia’s five-year average P/E is 33; looked at that way, NVDA is dirt-cheap.

 

  • The 12 Best Tech Stocks for a 2019 Recovery
Skip advert
Skip advert
Skip advert

3 of 7

Cummins

Hannover, Germany - September 21th, 2016: Presentation of truck and buses engines from Cummins on the motor show. The engine producer presented new generation diesel engines. On the first pla

Getty Images

Skip advert
  • 52-week low/high: $124.40/$194.18
  • Market value: $22.0 billion
  • P/E ratio: 9
  • Dividend yield: 3.3%
  • Cummins (CMI, $137.20) is down 29% from its high; thus, it’s in Dodson’s sweet spot. Unlike Dodson’s tech stocks, Cummins is based in Indiana, far from Silicon Valley. The company makes and services diesel engines and components, as well as natural gas engines. It also makes standby electrical power generational systems used by hospitals, data centers and other users requiring uninterrupted electrical power. Almost half of Cummins’ sales are outside the U.S., so it’s another stock that could be hurt by trade disputes.

In recent years, Cummins has benefited from rising fuel efficiency standards and tighter emissions regulations. However, CMI shares could be hurt by the Trump administration’s rollback of those standards and its embrace of coal and other comparatively dirty fossil fuels. And because its engines are used primarily in trucks, the company’s sales are closely tied to the economy. Any slowing in the economy globally, which we’re already seeing, could hurt its sales and earnings.

Still, Cummins, which is 100 years old, has developed a reputation for producing superior and innovative engines and related products. And with a forward P/E of 9, compared to a five-year average P/E of 13, CMI looks like a winner.

Skip advert
Skip advert
Skip advert

4 of 7

International Business Machines

Dubai, UAE - March 4, 2012: IBM headquarters in Dubai, UAE. IBM headquarters is located in the vast territory of Dubai Internet City. One of the oldest and largest companies in the world in t

Getty Images

Skip advert
  • 52-week low/high: $105.54/$171.13
  • Market value: $108.9 billion
  • P/E ratio: 9
  • Dividend yield: 5.2%
  • International Business Machines (IBM, $119.83) is a lumbering giant whose best years were decades ago. But it’s still a behemoth in IT with more than a century in business behind it. IBM has operations in more than 170 countries, and much of its revenue comes from long-held contracts with the largest multi-national companies. These long-term contracts tend to lead companies to sign up with IBM for new services and products.

Last fall, IBM announced its acquisition of Red Hat for $34 billion – a 63% premium over Red Hat’s share price. The deal – the largest software acquisition ever – is all about building a bigger market in cloud computing. IBM CEO Ginni Rometty said: “IBM will become the world’s No. 1 hybrid cloud provider, offering companies the only open cloud solution that will unlock the full value of the cloud for their business.”

Becoming a big player in the cloud business could revive enthusiasm around the stock, Dodson says. IBM trades at 9 times trailing earnings, versus a five-year average of 10, and Dodson argues it doesn’t require much positive news to make it an attractive stock.

 

  • The 9 Best Stocks of America’s Last Bear Market
Skip advert
Skip advert
Skip advert

5 of 7

Applied Materials

Getty Images

Skip advert
  • 52-week low/high: $28.79/$62.40
  • Market value: $31.5 billion
  • P/E ratio: 9
  • Dividend yield: 2.4%
  • Applied Materials (AMAT, $32.91) is one of the world’s largest makers of tools and equipment used to make virtually every type of semiconductor. Its products are used in almost every chip-manufacturing facility in the world, Morningstar says. It spends $2 billion per year on research and development to keep up with innovative technologies.

Since peaking in price last March, AMAT has been on a bumpy road down. As we all discovered in the tech bubble and burst of 2000-02, the tech industry is subject to vicious boom-and-bust cycles. The question for investors: Are we near the bottom of the cycle? Applied’s price has fallen from its $62.40 high to a low of about half that. It currently trades at nearly $33 per share and has a P/E of 9. Its five-year average P/E is 16.

“At this price it’s a bargain,” Dodson says. “You have to buy it when things look bad. If you’re making semiconductors, you almost have to use Applied Materials equipment.”

Like most cyclicals, AMAT is a stock you may be better off “renting” for a year or two rather than holding for the long term.

 

  • 20 Expert Market Outlooks for 2019
Skip advert
Skip advert
Skip advert

6 of 7

Biogen

pipette over test tube dropping sample chemical into sample herbal plaint , biotechnoloy research concept

Getty Images

Skip advert
  • 52-week low/high: $249.17/$388.67
  • Market value: $65.4 billion
  • P/E ratio: 12
  • Dividend yield: N/A
  • Biogen (BIIB, $324.44) has several blockbuster medications on the market for multiple sclerosis and cancer, as well as as a robust pipeline of drugs in clinical trials for neurological and neurodegenerative diseases, including Alzheimer’s.

A cure for Alzheimer’s, which afflicts millions of people worldwide, has long been the Holy Grail for biotechnology researchers. So far, all the drugs developed have fallen far short of becoming effective treatments. But, if and when breakthroughs come, Cambridge, Mass., based Biogen might well be part of the solution.

Much as pharmaceutical companies are forced to lower their prices when their exclusive-use patents expire and cheaper generics come to market, biosimilars offer price competition to biotechnology medications from Biogen and other biotech companies. But biosimilars are more complicated to develop and bring to market than generic drugs. How that process unfolds will depend partly on science, but also on legislation and regulation.

Biogen’s stock peaked last July, but it has bounced much farther and faster than the market since the U.S. stock rally began Dec. 26. It currently trades near $324, roughly 12 times trailing earnings.

“We think it’s a terrific company,” Dodson says. “It’s highly profitable, and the floor for its P/E has been 17 in recent history.”

 

  • The 10 Best Health Care Stocks to Buy for 2019
Skip advert
Skip advert
Skip advert

7 of 7

Gilead Sciences

Getty Images

Skip advert
  • 52-week low/high: $60.32/$89.54
  • Market value: $88.0 billion
  • P/E ratio: 10
  • Dividend yield: 3.3%
  • Gilead Sciences (GILD, $68.09) is highly profitable largely because of sales of two drugs for HIV and another drug for Hepatitis C. The Hepatitis C drug, Dodson says, would be more profitable except that it requires only short-term treatment to cure almost all cases of what was an often fatal disease. The HIV drugs need to be taken for many years.

Gilead is working on new and better drugs for HIV and Hepatitis C, as well as other infectious diseases. Through acquisitions, Gilead has broadened its focus to include cancer and pulmonary and cardiovascular diseases. “The company has a history of discovering new drugs and of acquiring drugs developed by other firms,” Dodson says.

Gilead peaked in price more than a year ago. Like Biogen, it took off the day after Christmas with the rest of the market, then kept on climbing. Both companies drew buyers on word of Bristol-Myers Squibb’s (BMY) deal to acquire biotech firm Celgene (CELG).

The stock currently trades near $68. Its P/E is 10, compared to a five-year P/E of 9.

Steve Goldberg is an investment adviser in the Washington, D.C., area.

 

Skip advert
Skip advert
Skip advert
  • dividend stocks
  • tech stocks
  • bonds
  • stocks to buy
  • investing
  • Apple (AAPL)
  • Investing for Income
Share via EmailShare on FacebookShare on TwitterShare on LinkedIn
Skip advert
Skip advert
Skip advert
Skip advert

Recommended

5 Best Dow Dividend Stocks to Buy Now
blue chip stocks

5 Best Dow Dividend Stocks to Buy Now

This mini-portfolio of blue-chip dividend payers is positioned well to both generate income and tackle headline headwinds for the rest of 2022.
June 27, 2022
Move Over ETFs: Direct Indexing Is an Investment Strategy Worth Paying Attention to
investing

Move Over ETFs: Direct Indexing Is an Investment Strategy Worth Paying Attention to

More flexibility, more control, the potential for higher returns and tax-reducing strategies: With pros like that, could direct indexing be right for …
June 25, 2022
Kiplinger's Weekly Earnings Calendar
stocks

Kiplinger's Weekly Earnings Calendar

Check out our earnings calendar for the upcoming week, as well as our previews of the more noteworthy reports.
June 24, 2022
10 Smart AI Stock Picks
tech stocks

10 Smart AI Stock Picks

AI stocks have been bloodied up in 2022, but the technology's relentlessly growing importance should see the sun shine on them again.
June 23, 2022

Most Popular

8 Money Tips for Seniors Suffering from Inflation
Inflation

8 Money Tips for Seniors Suffering from Inflation

This year has been an especially tough one for seniors on fixed incomes. To stay on track, try these eight financial survival tips.
June 26, 2022
Your Guide to Roth Conversions
Special Report
Tax Breaks

Your Guide to Roth Conversions

A Kiplinger Special Report
February 25, 2021
An Easy Way to Find How Much You Will Spend in Retirement
retirement planning

An Easy Way to Find How Much You Will Spend in Retirement

One simple math equation can help you determine where to start building your retirement income plan, and whether your money should last.
June 27, 2022
  • Customer Service
  • About Us
  • Advertise With Us (PDF)
  • Privacy Policy
  • Cookie Policy
  • Kiplinger Careers
  • Accessibility
  • Privacy Preferences

Subscribe to Kiplinger's Personal Finance

Be a smarter, better informed investor.
Save up to 76%Subscribe to Kiplinger's Personal Finance
Do Not Sell My Information

Kiplinger is part of Future plc, an international media group and leading digital publisher. Visit our corporate site www.futureplc.com
© Future US LLC, 10th floor, 1100 13th Street NW, Washington, DC 20005. All rights reserved.

Follow us on InstagramFollow us on FacebookFollow us on TwitterConnect on LinkedInConnect on YouTube